Matching Geography

Reports matching your search in:
 
 

Research Assistance

 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!
 

Gene Therapy

1594

Gene therapy is a technique used to treat or prevent diseases by the insertion, replacement reparation, regulation or removal of genes within an individual’s cells and biological tissues.

The most common approach to gene therapy is insertion, by which a functional gene is inserted into the genome to replace a disease-causing mutated gene. Another method is modifying the gene sequence by substituting a mutated gene through homologous recombination.

Selective reverse mutation is a type of gene therapy in which an abnormal gene is repaired and returned to its normal function. Gene regulation involves the “turning on or turning off” of a particular gene to alter its functionality.

Types of gene therapy include germ line gene therapy and somatic gene therapy. In germ-line gene therapy, germ cells (i.e. sperms or eggs) are modified by the insertion of functional genes. These genetic changes would be heritable and theoretically passed on to future generations. In somatic gene therapy, genes are transferred into somatic cells, effecting only the patient with no risk to passing on the altered genes to offspring.

RSS Feeds

All reports in Gene Therapy

< prev 1  2  next >
Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders
4/12/2012 | published by: GlobalData
... blood disorders such as beta-thalassemia and sickle cell anemia. An international team of researchers led by scientists at Weill-Cornell Medical College in New York City have designed a novel gene therapy strategy with potentially curative ...  |  more...
$500.00
Global Gene Therapy Market Analysis
4/1/2012 | published by: RNCOS
... generation, the gene therapy market holds tremendous growth potential. As per a new estimation, carried out in our latest study, the global gene therapy industry will reach US$ 325 Million by the end of 2015 ...  |  more...
$1,200.00
Gene Therapy in Oncology Drug Pipeline Update 2012
2/21/2012 | published by: BioSeeker Group AB
... years amount to another 94 drugs. Gene Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 88 different targets. ...  |  more...
$2,249.00
Gene Therapy
2/1/2012 | published by: Global Industry Analysts
... such as AnGes MG, Inc., BioSante Pharmaceuticals, GenVec, Oxford BioMedica, Shenzhen SiBiono GeneTech Co., Ltd., Transgene, and Vical Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based ...  |  more...
$4,500.00
Emerging Drug Delivery Technologies & Strategies - Players, Pipelines & Partnerships
9/12/2011 | published by: Espicom Healthcare Intelligence
An examination of trends and advances in the three major drug delivery sectors Unique sales forecasts to 2020 for key products Critical analyses of 58 specialist developers driving the drug delivery market onwards  |  more...
$2,265.00
Plunkett's Biotech & Genetics Industry Trends & Statistics 2012: A Summary Version of Plunkett's Biotech & Genetics Industry Almanac 2012
9/1/2011 | published by: Plunkett Research, Ltd.
... as statistical tables-a tool for strategic planning, business development or industry analysis. Trends analyzed range from the convergence of nanotechnology and biotechnology, to the evolution of breakthrough new drug delivery systems, to the abounding ethical ...  |  more...
$149.99
Plunkett's Biotech & Genetics Industry Almanac 2012: Biotech & Genetics Industry Market Research, Statistics, Trends & Leading Companies
9/1/2011 | published by: Plunkett Research, Ltd.
... to search and export data at Plunkett Research Online A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms. You will gain vital insights that can help you ...  |  more...
$299.99
Translational Regenerative Medicine: Market Prospects 2011-2021
7/27/2011 | published by: Visiongain
... therapy. Through our research and analysis we aim to save you time and help in your decisions. What technologies and applications will expand that market? What will stimulate and limit regenerative medicine? See potential revenues ...  |  more...
$2,331.00
Gene Therapy
1/1/2011 | published by: Global Industry Analysts
... such as AnGes MG Inc., BioSante Pharmaceuticals, GenVec, Genzyme Corporation, Oxford BioMedica, Shenzhen SiBiono GeneTech Co., Ltd., Transgene, and Vical Inc. Market data and analytics are derived from primary and secondary research. Company profiles are ...  |  more...
$4,500.00
Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
12/1/2010 | published by: Kalorama Information
... other novel compounds targeting drugs to specific disease sites including gene therapy. Treatments for chronic conditions and growth in patient-administered drugs are factors leading to greater focus on ease-of-use and convenience. Advanced Drug Delivery Markets ...  |  more...
$2,500.00
Epigenetics: Current And Future Applications That Are Driving Novel Drug Discovery
8/25/2010 | published by: Espicom Healthcare Intelligence
This new 75+ page August 2010 report provides a complete briefing on the emerging importance of epigenetic research in drug and diagnostic development.  |  more...
$1,215.00
Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009 - 2014)
7/21/2010 | published by: MarketsandMarkets
... to integrate biological data. Pharmaceutical companies are now adopting automated technologies to manufacture effective therapies and drugs due to increasing concerns about drug safety and the stringent regulations that govern clinical trials for drug discovery. ...  |  more...
$4,650.00
Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
2/1/2010 | published by: GBI Research
... Unmet Needs in Pharma”, which provides insights into the unmet needs in the pharmaceutical and healthcare market and potential segments where RNA therapies can prove to be useful. This pharma report also delves deep into ...  |  more...
$3,500.00
Epigenetics
2/1/2010 | published by: Global Industry Analysts
... companies including many key and niche players worldwide such as Celgene Corporation, CellCentric Ltd., CellCentric Ltd., Epigentek Group, Inc., Genpathway, Inc., Merck & Co., Inc., MGI Pharma, Inc., Millipore Corporation, OncoMethylome Sciences S.A., and Orion ...  |  more...
$4,500.00
Opportunities in Human Embryonic Stem Cell (hESC) Products
1/1/2010 | published by: BioInformant Worldwide, L.L.C.
... types and can develop into over 200 different cell types of the human body, providing tremendous therapeutic potential. Human ESCs were first derived from mouse embryos in 1981 by Martin Evans and Matthew Kaufman, and ...  |  more...
$3,495.00
U.S. Epigenetics Markets
12/31/2009 | published by: Frost & Sullivan
... and chromatin immunoprecipitation segments. Each segment covers competitive structure, market share analysis, revenue forecasts, and product analysis. The key market drivers and restraints, challenges, strategies, and competitive factors are covered for the total market overview.  |  more...
$6,000.00
Stakeholder Opinions: Gene Therapy - Gene therapy to deliver after 20 years of clinical development
12/10/2009 | published by: Datamonitor
... gene therapy as a therapeutic delivery tool has enhanced the technology's commercial potential over the last 10 years. Scope In-depth analysis of the current gene therapy clinical pipeline. Analysis of key target indications for gene ...  |  more...
$3,800.00
Innovations In Epigenetics: Advances in Technologies, Diagnostics & Therapeutics
11/26/2009 | published by: Business Insights
... and influence disease progression. Three main mechanisms - DNA methylation, histone modifications and changes in non-coding RNA - have been elucidated in epigenetics. Each in its own way may provide the industry with a greater ...  |  more...
$3,835.00
Global Stem Cell and Advanced Technologies Market
11/1/2009 | published by: MarketsandMarkets
... embryo stem cells are expected to drive the growth of the overall market. In addition, intensive R&D efforts and the increasing investments into research on stem cells therapy are soon expected to improve the efficacy ...  |  more...
$4,650.00
Advances in the Stem Cell Industry: The future impact of innovation, and an evaluation of the commercial landscape
10/1/2009 | published by: Business Insights
... stem (IPS) cells; they offer an alternative to using embryonic stem cells. This report takes the implications of IPS cells and other developments into account. Some essential technologies are already in place and stem-cell based ...  |  more...
$3,835.00
The 2009-2014 World Outlook for Gene Therapy
7/7/2009 | published by: Icon Group International, Inc.
... question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ...  |  more...
$795.00
Stem Cell Therapeutics Markets
2/1/2009 | published by: Kalorama Information
... to move forward with stem cell research. The momentum in two branches of American government, along with scientific developments and the competition of world markets presages good market conditions for stem cell research. With their ...  |  more...
$2,500.00
Gene Expression Profiling Markets
1/1/2008 | published by: Kalorama Information
... see revenues grow rapidly. However, different products and applications are increasingly being introduced, making the market more fragmented as well as unpredictable. In terms of application, too, the landscape is shifting. Although life-science research is ...  |  more...
$1,500.00
Brand Positioning: Gene Expression Analysis Products
10/1/2007 | published by: BioInformatics, LLC
... Using advanced statistical analysis this report will examine brand positioning in the gene expression analysis product category. We have defined this market as being primarily composed of consumable products used for measuring mRNA levels to ...  |  more...
$5,000.00
Top Companies and Products in the RNA/DNA Therapy Products Market Forecasts: The Challenge of Turning Technology into Therapy
7/23/2007 | published by: Visiongain
... pharmaceutical companies Pfizer, Sanofi-Aventis, Eli Lilly & Company and Merck & Co all have substantial investment in the RNA/DNA therapy products market. With Merck & Co in particularly showing its faith in the future potential ...  |  more...
$2,210.00
< prev 1  2  next >